| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 49 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 47 |
| 2 | TACROLIMUS OINTMENT 0.1% | 47 |
| 3 | MYCOPHENOLATE MOFETIL | 29 |
| 4 | PREDNISONE | 29 |
| 5 | VALGANCICLOVIR | 19 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE | 19 |
| 7 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 18 |
| 8 | METHYLPREDNISOLONE | 15 |
| 9 | PREDNISOLONE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FEBUXOSTAT TABLETS 40 MG | 11 | 0.0011 |
| 1 | VALGANCICLOVIR | 19 | 0.0010 |
| 2 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 3 | FEBUXOSTAT | 11 | 0.0006 |
| 4 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 4 | 0.0005 |
| 5 | GANCICLOVIR SODIUM | 5 | 0.0005 |
| 6 | TACROLIMUS OINTMENT 0.1% | 47 | 0.0004 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 47 | 0.0004 |
| 8 | CLOTRIMAZOLE TOPICAL | 4 | 0.0003 |
| 9 | CLOTRIMAZOLE | 4 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 22 | 0.0010 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 12 | 0.0001 |
| 5 | Nucleoside Analog Antiviral [EPC] | 5 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 47 | 0.0000 |
| 8 | Azole Antifungal [EPC] | 4 | 0.0000 |
| 9 | Protease Inhibitor [EPC] | 1 | 0.0000 |